Stock Track | Ionis Pharmaceuticals Plunges 5.20% in Pre-Market on Widening Q4 Loss

Stock Track02-25

Ionis Pharmaceuticals' stock experienced a significant pre-market plunge of 5.20% on Wednesday, as investors reacted to the company's latest quarterly financial results.

The biopharmaceutical company reported mixed fourth-quarter earnings, with revenue of $203 million beating the Ibes estimate of $156.1 million and adjusted operating income of -$172 million coming in better than the expected -$210.3 million. However, the company's earnings per share forecast showed a loss of $1.32, significantly wider than the prior-year period's loss of $0.66 cents.

Despite beating revenue and operating income estimates, the substantial increase in per-share losses appears to have driven negative investor sentiment during pre-market trading, overshadowing the positive aspects of the earnings report.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137555034?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 20:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137555034","market":"hk","top_or_hot":-1,"title":"Stock Track | Ionis Pharmaceuticals Plunges 5.20% in Pre-Market on Widening Q4 Loss","media":"Stock Track","content":"<p>Ionis Pharmaceuticals' stock experienced a significant pre-market plunge of 5.20% on Wednesday, as investors reacted to the company's latest quarterly financial results.</p><p>The biopharmaceutical company reported mixed fourth-quarter earnings, with revenue of $203 million beating the Ibes estimate of $156.1 million and adjusted operating income of -$172 million coming in better than the expected -$210.3 million. However, the company's earnings per share forecast showed a loss of $1.32, significantly wider than the prior-year period's loss of $0.66 cents.</p><p>Despite beating revenue and operating income estimates, the substantial increase in per-share losses appears to have driven negative investor sentiment during pre-market trading, overshadowing the positive aspects of the earnings report.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Ionis Pharmaceuticals Plunges 5.20% in Pre-Market on Widening Q4 Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Ionis Pharmaceuticals Plunges 5.20% in Pre-Market on Widening Q4 Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-25 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ionis Pharmaceuticals' stock experienced a significant pre-market plunge of 5.20% on Wednesday, as investors reacted to the company's latest quarterly financial results.</p><p>The biopharmaceutical company reported mixed fourth-quarter earnings, with revenue of $203 million beating the Ibes estimate of $156.1 million and adjusted operating income of -$172 million coming in better than the expected -$210.3 million. However, the company's earnings per share forecast showed a loss of $1.32, significantly wider than the prior-year period's loss of $0.66 cents.</p><p>Despite beating revenue and operating income estimates, the substantial increase in per-share losses appears to have driven negative investor sentiment during pre-market trading, overshadowing the positive aspects of the earnings report.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IONS","symbol_name":"Ionis Pharmaceuticals, Inc","start_time":0,"source_url":"","article_id":"1137555034","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137555034","pubTimestamp":1772021196,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Ionis Pharmaceuticals' stock experienced a significant pre-market plunge of 5.20% on Wednesday, as investors reacted to the company's latest quarterly financial results.The biopharmaceutical company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IONS":"Ionis Pharmaceuticals, Inc"},"translate_title":"个股追踪|Ionis Pharmaceuticals盘前暴跌5.20%因Q4亏损扩大","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IONS":1},"content_text":"Ionis Pharmaceuticals' stock experienced a significant pre-market plunge of 5.20% on Wednesday, as investors reacted to the company's latest quarterly financial results.The biopharmaceutical company reported mixed fourth-quarter earnings, with revenue of $203 million beating the Ibes estimate of $156.1 million and adjusted operating income of -$172 million coming in better than the expected -$210.3 million. However, the company's earnings per share forecast showed a loss of $1.32, significantly wider than the prior-year period's loss of $0.66 cents.Despite beating revenue and operating income estimates, the substantial increase in per-share losses appears to have driven negative investor sentiment during pre-market trading, overshadowing the positive aspects of the earnings report.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137555034","isCrawlerRequest":true}